Mortality of Patients With Renal Dysfunction After Percutaneous Coronary Intervention

Abstract

Aim: To determine the impact of stages of renal dysfunction on mortality after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). Patients and Methods: A total of 449 patients (mean age 63 ± 11.9 years) with ACS after PCI were included. Serum creatinine was determined and creatinine clearance was calculated using the Modification of Diet in Renal Disease (MDRD) formula. Results: The prevalence of chronic kidney disease (CKD) defined as glomerular filtration rate (GFR) 2was 26.3%. After up to 787 days of follow-up, 40 patients had died. Kaplan-Meier survival analysis showed progressively higher risk for cardiovascular death from stage 1 to stage 4 of renal dysfunction. In an adjusted Cox model, gender (P < .009), age (P < .0001), total cholesterol level (P < .01), and stage of renal dysfunction (P < .04) were predictors of mortality. Conclusions: In patients with ACS after PCI, a higher stage of renal dysfunction was directly associated with higher mortality of these patients.